Melissa B. Epperly, Chief Financial Officer at Zentalis Pharmaceuticals, Inc. (ZNTL), sold 6,166 shares at $41.67 ($257K) on 2021-03-01, disclosed to the SEC on 2021-03-03.
Open-market sale of $257k ZNTL by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.67 | 3,083 | $128K | 50.0% |
| 2 | $41.67 | 3,083 | $128K | 50.0% |
| Total | $41.67 avg | 6,166 | $257K | 100% |
| Filing → |
| ROIV | SELL | 2026-07-01 | $610K | — | Filing → |
| ROIV | SELL | 2026-03-18 | $1.2M | — | Filing → |
| ZNTL | SELL | 2024-02-12 | $29K | — | Filing → |